Nea Management Company, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Nea Management Company, LLC

  • $1.06 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.7 - $1.07 $489,204 - $747,783
-698,863 Reduced 23.35%
2,294,095 $1.61 Million
Q4 2022

Feb 10, 2023
SELL
$0.61 - $5.06 $91,500 - $758,999
-150,000 Reduced 4.77%
2,992,958 $2.69 Million
Q2 2021

Aug 02, 2021
BUY
$4.8 - $7.25 $697,324 - $1.05 Million
145,276 Added 4.85%
3,142,958 $22.2 Million
Q1 2021

May 14, 2021
BUY
$4.57 - $7.18 $13.7 Million - $21.5 Million
2,997,682 New
2,997,682 $17.7 Million

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email